CorEvitas is now part of Thermo Fisher Scientific. Read More.
The CorEvitas RA Registry is the largest RA real world prospective cohort study in the world. We collect data from both physicians and patients at the time of a clinical encounter and longitudinally thereafter.
432000+
STUDY VISITS
56000+
PATIENTS
850+
RHEUMATOLOGISTS
Participating Sites
CorEvitas has clinical sites across the U.S. and we are always interested in expanding the registry for qualified sites.
